Researchers closing in on genetic treatments for hereditary lung disease, vision loss

6 March 2024

- Advertisement -

Researchers who work with tiny drug carriers known as lipid nanoparticles have developed a new type of material capable of reaching the lungs and the eyes, an important step toward genetic therapy for hereditary conditions like cystic fibrosis and inherited vision loss.